These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17986480)

  • 1. Regulators of cytokine signalling in rheumatoid arthritis.
    Rahman A
    Rheumatology (Oxford); 2007 Dec; 46(12):1745-6. PubMed ID: 17986480
    [No Abstract]   [Full Text] [Related]  

  • 2. The transfer of a laboratory based hypothesis to a clinically useful therapy: the development of anti-TNF therapy of rheumatoid arthritis.
    Feldmann M; Brennan FM; Williams RO; Woody JN; Maini RN
    Best Pract Res Clin Rheumatol; 2004 Feb; 18(1):59-80. PubMed ID: 15123038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel approaches for the treatment of rheumatoid arthritis: lessons from the evaluation of synovial biomarkers in clinical trials.
    Gerlag DM; Tak PP
    Best Pract Res Clin Rheumatol; 2008 Apr; 22(2):311-23. PubMed ID: 18455687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging targets of biologic therapies for rheumatoid arthritis.
    Tarner IH; Müller-Ladner U; Gay S
    Nat Clin Pract Rheumatol; 2007 Jun; 3(6):336-45. PubMed ID: 17538565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of infliximab therapy on biological markers of synovium activity and cartilage breakdown in patients with rheumatoid arthritis.
    Marotte H; Gineyts E; Miossec P; Delmas PD
    Ann Rheum Dis; 2009 Jul; 68(7):1197-200. PubMed ID: 18713784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adhesion molecule in pathogenesis of rheumatoid arthritis].
    Origuchi T; Eguchi K
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():200-7. PubMed ID: 15799346
    [No Abstract]   [Full Text] [Related]  

  • 7. Detection, identification and in vivo treatment responsiveness of bone morphogenetic protein (BMP)-activated cell populations in the synovium of patients with rheumatoid arthritis.
    Verschueren PC; Lories RJ; Daans M; Théate I; Durez P; Westhovens R; Luyten FP
    Ann Rheum Dis; 2009 Jan; 68(1):117-23. PubMed ID: 18276742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to the commentary 'Pooled indices to measure rheumatoid arthritis activity: a good reflection of the physician's mind'.
    Vander Cruyssen B; Durez P; Westhovens R; Vastesaeger N; Geldhof A; De Keyser F
    Arthritis Res Ther; 2006; 8(6):406. PubMed ID: 17049071
    [No Abstract]   [Full Text] [Related]  

  • 9. Synovial tissue sublining CD68 expression is a biomarker of therapeutic response in rheumatoid arthritis clinical trials: consistency across centers.
    Bresnihan B; Pontifex E; Thurlings RM; Vinkenoog M; El-Gabalawy H; Fearon U; Fitzgerald O; Gerlag DM; Rooney T; van de Sande MG; Veale D; Vos K; Tak PP
    J Rheumatol; 2009 Aug; 36(8):1800-2. PubMed ID: 19671815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of disease-modifying antirheumatic drug treatment on the expression of RANKL and osteoprotegerin in synovial tissue: comment on the article by Haynes et al.
    Catrina AI; Klareskog L
    Arthritis Rheum; 2008 Nov; 59(11):1685; author reply 1685-6. PubMed ID: 18975354
    [No Abstract]   [Full Text] [Related]  

  • 11. [Biochemical markers of bone turnover. New aspect. Therapy of rheumatoid arthritis for bone metabolic marker].
    Okada Y; Nawata M; Tanaka Y
    Clin Calcium; 2009 Aug; 19(8):1186-90. PubMed ID: 19638703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine networks--towards new therapies for rheumatoid arthritis.
    McInnes IB; Liew FY
    Nat Clin Pract Rheumatol; 2005 Nov; 1(1):31-9. PubMed ID: 16932625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rituximab (Mabthera)--new approach in treatment of rheumatoid arthritis].
    Anić B
    Reumatizam; 2007; 54(2):72-3. PubMed ID: 18351146
    [No Abstract]   [Full Text] [Related]  

  • 14. Modulatory effects of inflammation and therapy on GDF-5 expression in rheumatoid arthritis synovium.
    Bramlage CP; Kaps C; Ungethüm U; Bramlage P; Koziolek M; Wessels J; Krenn V; Pruss A; Müller GA; Strutz F; Burmester GR; Häupl T
    Scand J Rheumatol; 2008; 37(6):401-9. PubMed ID: 18830904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid interaction between CTLA4-Ig (abatacept) and synovial macrophages from patients with rheumatoid arthritis.
    Brizzolara R; Montagna P; Soldano S; Cutolo M
    J Rheumatol; 2013 May; 40(5):738-40. PubMed ID: 23637380
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis of apoptosis in peripheral blood and synovial tissue very early after initiation of infliximab treatment in rheumatoid arthritis patients.
    Wijbrandts CA; Remans PH; Klarenbeek PL; Wouters D; van den Bergh Weerman MA; Smeets TJ; Vervoordeldonk MJ; Baeten D; Tak PP
    Arthritis Rheum; 2008 Nov; 58(11):3330-9. PubMed ID: 18975323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac complications may be higher with use of proteasome inhibitors in patients with rheumatoid arthritis.
    Khan S
    Med Hypotheses; 2008 Nov; 71(5):818. PubMed ID: 18650027
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanism for spread of rheumatoid arthritis.
    Nurse Educ; 2010; 35(2):55. PubMed ID: 20173587
    [No Abstract]   [Full Text] [Related]  

  • 19. [Rituximab: a new therapeutic arm in refractory rheumatoid arthritis: about one case].
    Abdelmoula LC; Testouri N; Ben Hadj Yahia C; Tekaya R; Ben M'barek R; Chaabouni L; Zouari R
    Tunis Med; 2008 Sep; 86(9):841-2. PubMed ID: 19472790
    [No Abstract]   [Full Text] [Related]  

  • 20. Responsiveness to anti-tumour necrosis factor alpha therapy is related to pre-treatment tissue inflammation levels in rheumatoid arthritis patients.
    van der Pouw Kraan TC; Wijbrandts CA; van Baarsen LG; Rustenburg F; Baggen JM; Verweij CL; Tak PP
    Ann Rheum Dis; 2008 Apr; 67(4):563-6. PubMed ID: 18042642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.